Dr Martens has insisted trading since the start of its financial year has remained in line with expectations, ahead of its annual general meeting (AGM) this morning.
The footwear retailer said its guidance for FY25 was unchanged, and highlighted that its first quarter, as always, was its smallest period of the financial year, representing the end of the spring/summer season.
It claimed its current financial year would be very second-half weighted, particularly in terms of profit.
Dr Martens said its autumn/winter season remained a key focus for the brand, with detailed trading plans being implemented.
Related Story
It also noted that it was continuing to target positive direct to consumer growth in the US during its second half, after reporting weak US consumer demand for its full year in May.
The retailer said work on its cost action plan was ongoing and that it would be providing a detailed update during its first half results in November.
Click here to sign up to Retail Gazette‘s free daily email newsletter
